Increasing evidence points to mitochondrial dysfunction in I Control Parkinson's disease (PD) associated with complex I dysfunction, but the exact pathways which lead to cell death have not been resolved. 2D-gel electrophoresis profiles of isolated mitochondria from neuroblastoma cells treated with subcytotoxic concentrations of l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP), a well-characterized complex I inhibitor, were assessed to identify associated targets. Up to 27 differentially expressed proteins were observed, of which 16 were identified using peptide mass fingerprinting. Changes in protein levels were validated by immunoprobing ID blots, confirming increases in heat shock cognate 71 kDa (Hsc70), 60 kDa heat shock protein (Hsp60), fumarase, glutamate oxaloacetate transaminase 2, ATP synthase subunit d, and voltage-dependent anion-channel 1 (VDACl). Immunoprobing of 2D blots revealed isoform changes in Hsc70, Hsp60, and VDACl. Subcyto toxic concentrations of MPTP modulated a host of mitochondrial proteins including chaperones, metabolic enzymes, oxidative phosphorylation-related proteins, an inner mitochondrial protein (mitofilin), and an outer mitochondrial membrane protein (VDACl). Early changes in chaperones suggest a regulated link between complex 1 inhibition and protein folding. VDACl, a multifunctional protein, may have a key role in signaling between mitochondria and the rest of the cell prior to cell death. Our work provides new important information of relevance to PD.
• INTRODUCTION
Parkinson's disease (PD) is the second most common neu-26 rodegenerative condition affecting 1 to 2% of the world's 27 population over the age of 60. It is a progressive neurological 28 movement disorder characterized by the selective degeneration 29 of dopaminergic neurons, mainly in the substantia nigra pars 30 compacta, linked with formation of proteinaceous inclusions, 31 commonly known as Lewy bodies. Current treatments, invol-32 ving maintenance of dopamine levels, alleviate the symptoms but 33 do not prevent neurodegeneration, due to the fact that the exact 34 pathways involved in the disease have not been completely 35 resolved. Several hypotheses have been proposed including 36 mitochondrial dysfunction, protein degradation impairment, 37 defects in calcium homeostasis, glutamate excitotoxicity, inflam-38 mation, and oxidative stress. ' Whether these features are 39 linked, how they lead to neurodegeneration, and which are 40 primary and secondary effects still remain unsolved. 41 Mitochondrial dysfunction has been observed in both idio-42 pathic and genetic forms of PD. For example, complex I activity 43 of the electron transport chain (ETC) was up to 30% lower in 44 brain, muscle, and platelets from PD patients and coenzyme Q_ 45 10, an essential cofactor in the ETC, was decreased in PD 46 patients; both characteristics would lead to increased intracel-47 hilar oxidative stress, proton gradient impairment, and reduced 48 ATP production. Additionally, DJ-1, PINK1, and the protease 49
Htra2/Omi have all been linked to genetic forms of the disease and are all localized in mitochondria and/or linked to mitochondrial function. The neurotoxin l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP) was originally observed to reproduce Parkinson's like symptoms in heroin addicts ingesting a synthetic narcotic containing the toxic substance. It has since been shown that MPTP can be metabolized by monoamine-oxidase (MAO)-B into a toxic product, l-methyl-4-phenylpyrimidium (MPP ), which primarily targets nigrostriatal dopaminergic neurons via the dopamine uptake system, leading to inhibition of complex I of the ETC ' and cell death. MPTP became of particular interest when it was found to reproduce symptomatic, pathological, and biochemical features of PD in animal models ' and is one of the most commonly used pharmacology-based model of PD, both in vivo and in vitro.
Proteomic approaches of relevance to PD have only emerged in the past decade, mostly concentrating on total cell extracts from a variety of experimental models, models involving both genetic or pharmacologic approaches, in vivo and in vitro. These include the effects of MPTP or MPP on mice, using 2D-gel electrophoresis (2DE) or shotgun approaches, ' and on human neuroblastoma cells using 2DE. Many of these studies have led to the creation of lists of differentially expressed proteins containing 10-100 identities that do not always agree depending on the model, the approach, and the part of animal brain studied, 
• EXPERIMENTAL SECTION m

Cell Culture and Treatments 165
Mouse N2a neuroblastoma cells (ICN, U.K.) were maintained 166 as a monolayer in growth medium containing Dulbeco's mod-167 ified Eagle's medium (DMEM), 10% (v/v) fetal bovine serum, 168 2 mM 2-L-glutamine, 100 units/mL penicillin and 100 units/mL 169 streptomycin (Lonza, U.K.). Cells were incubated and main-170 tained at 60-85% confluence at 37 °C in a humidified atmo-171 sphere of 95% air/5% C0 2 (v/v). For cell differentiation, cells 172 were plated at a density of 20 000 cells/cm and allowed to 173 recover for 24 h. The growth medium was then removed and 174 replaced by a differentiating medium containing 0.3 mM 175 dbcAMP (Sigma-Aldrich, U.K.), 2 mM 2-L-glutamine, 100 176 units/mL penicillin and 100 units/mL streptomycin in DMEM. dihydrogen orthophosphate, 0.2 g/L disodium hydrogen) were 254 added. The reaction was initiated with 50 flL of NADH (4 mM) 255 and absorbance was recorded every 15 s for 3 min using a spe-256 ctrophotometer at 340 nm. The mean specific activity per 257 microgram of protein for each fraction was normalized against 258 the specific activity of the total extract (given a value of l) and 259 data were expressed as mean ± SEM. 260
NADPH-cytochrome c Reductase 261 NADPH-cytochrome c reductase activity was used as a marker 262 of endoplasmic reticulum in each fraction. Assay buffer (l mL) 263 containing 50 mM sodium phosphate, 0.1 mM EDTA, pH 7.7, 50 264 flL of cytochrome c (25 mg/mL) and 50 fiL of fraction sample 265 were mixed prior to the addition of 100 fiL of NADPH (2 mg/ 266 mL). Absorbance was recorded every 15 s for 3 min at 550 nm. 267 The mean specific activity per microgram protein for each 268 fraction was normalized against the specific activity of the total 269 extract (given a value of l) and data were expressed as mean 270 ± SEM. 271
Western Blot Analysis 272
This either stored at -80 °C or processed immediately. For equilibration, strips were transferred to 2% (w/v) DTT in equilibration buffer (6 M urea, 2% (w/v) SDS, 20% (v/v) glycerol, 50 mM Tris pH 8.8,) followed by 15 min in 2.5% (w/v) iodoacetamide in equilibration buffer. The proteins were further fractionated by SDS-PAGE (as described above). For comparative purposes, gels were stained using SyproRuby dye following the manufacturer's instructions (invitrogen, U.K.). Gels were then imaged using a Fujifilm FLA-5100 scanner (Raytek Scientific Limited, Germany) and images were analyzed using Samespots software (Progenesis, U.K.). Data were transferred to the PG240 section of the software. Spots were selected if peak height was over 750 and observed as up-or down-regulated if p < 0.1 using paired t test carried out by the software and differentially expressed to more than 20% from one group to another. For identification of protein spots, gels were silver stained (PlusOne Silver staining kit, GE Healthcare) using a mass spectrometry compatible protocol. For 2D-blot analysis, gels were directly processed to wet blotting as described earlier.
Mass Spectrometry Analysis
Selected spots were excised from the gel, dehydrated in 50 fiL of acetonitrile (ACN)/25 mM NH 4 HC0 3 (2:l) for 15 min while shaking, rehydrated in 50 fiL of 25 mM NH 4 HC0 3 for 10 min, and then sequentially dehydrated, rehydrated, and dehydrated. Gel pieces were then dried and 15 fiL of 12.5 ng/fiL sequencing grade trypsin (Promega, U.K.) was added. Gel spots were incubated at 37 °C for 4 h. Tryptic digests were then transferred to fresh tubes and 10 fiL of 4:1 ACN/LC-MS grade water (v/v) was added to the gel pieces and left for 15 min while shaking. The supernatant was combined with the previous digest and 5 fiL of 0.1% trifluoroacetic acid (TFA) was added to each tube. Finally, 1 fiL sample was plated on the MALDI plate followed by 1 fiL of 10 mg a-cyano-4-hydroxycinnamic acid (CHCA) matrix (LaserBio Laboratories, France)/mL in 50% (v/v) ACN/0.1% (v/v) TFA. Peptide mass fingerprints were generated using a MALDI-TOF mass spectrometer (Axima mass spectrometer, Shimadzu, U.K.). Proteins were identified using the Mascot search engine (http://www.matrixscience.com); stating "mus musculus" species, carboxymethyl and oxidized methionine as variable modifications and 0.2 Da peptide tolerance. Positive identity was given by scores over 56 (comparing Swiss-Prot database) and their molecular mass and pi were compared to the position of the spot on the 2DE.
Statistical Analysis
Data were statistically analyzed by a paired t test using a twotailed distribution.
• RESULTS
MPTP Cytotoxicity in Differentiated Mouse N2a Neuroblastoma Cells
Following 16 h differentiation, N2a cells were treated with different concentrations of MPTP for either 24 or 48 h. Cytotoxic effects of MPTP were determined using a range of assays (Figure l) . Following 24 h exposure to MPTP, ATP levels dropped in a concentration dependent-manner; 10 fiM MPTP significantly decreased ATP levels by 25% and 2 mM MPTP reduced ATP by more than 80% ( Figure 1A ). Both trypan blue exclusion and MTT reduction assays showed that cell viability was significantly reduced following 24 h exposure to 2 mM MPTP but not at lower MPTP concentrations ( Figure 1A ). Table of quantified results from activity assays and Western blots using Ada software . Specific activity of each enzyme measured was calculated relative to total extract (given a value of l) ± SEM (n > 4). *All values p < 0.05 when compared to total extract using a paired r test with a two-tail distribution. Intensity of bands in each fraction was measured and quantified relative to total extracts (given a value of l) ± SEM (n > 13). Cyt c, cytochrome c; Cyto, cytoplasmic; ER endoplasmic reticulum; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; LAMP2, lysosomal-associated membrane protein 2; LDH, lactate dehydrogenase; Mito, mitochondrial; NADPH-cyt c reductase, nicotinamide adenine dinucleotide phosphate-cytochrome c reductase; SDH, succinate dehydrogenase.
By 48 h, 10 fiM MPTP reduced cell viability as measured by MTT and trypan blue ( Figure IB) . Following 24 h treatment, cell morphology indicated that cell death occurred at a concentration of 2 mM MPTP, represented by a reduction in cell volume, a spherical cell shape and a loss of membrane integrity ( Figure 1C) . Nevertheless, shortening of axon-like processes was apparent with MPTP concentrations as low as 10 fiM MPTP, exacerbated as MPTP concentration was increased. Following 48 h exposure, 10 fiM MPTP resulted in a few rounded dead cells; however, cell death was more evident with 100 fiM and higher concentrations of MPTP. To conclude, cell morphology and ATP levels were affected at lower MPTP concentrations than apparent cell death measured using trypan blue exclusion and MTT reduction. A concentration affecting morphology/ATP but not MTT reduction/trypan blue exclusion was defined as subcytotoxic and was chosen to observe changes occurring in the mitochondrial proteome prior to cell death. Consequently further analyses were carried out using 1 mM MPTP for 24 h.
Purity of Mitochondria-Enriched Fractions
The mitochondrial markers cytochrome c and SDH were highly enriched (4.5-and 13-fold, respectively) in the mitochondrial pellet, while present at low levels in the nuclear pellet and ) by2DE using pH3 -10 andpH5 -8 gradient strips, and proteins visualized using SyproRuby. Gel images were compared using Samespots software. Circled spots represent spots that changed in density (p < O.l) between 1 mM MPTP and control samples following a student paired t test. Alist of identified proteins affected by MPTP treatment is provided in Table 1 . highly depleted in the cytoplasmic fraction (Figure 2) . Cytoplasmic, nuclear and endoplasmic reticulum (ER) markers were minimal within the mitochondria-enriched fraction; however, the lysosomal marker LAMP2 appeared to be enriched in the mitochondrial fraction compared to the total extract but this was not stastistically significant. The majority of the lysosomal marker was present in the cytoplasmic fraction (enriched 4.4-fold compared to total extract; Figure 2 ). Overall, subcellular marker analysis showed that the mitochondrial fraction was composed mainly of mitochondrial proteins and contained a low level of the lysosomal protein marker. The cytoplasmic fraction also contained low levels of noncytoplasmic protein markers. Thus, both mitochondrial and cytoplasmic fractions were deemed to be suitable for further analyses. On the other hand, the nuclear fraction contained significant levels of cytoplasmic and mitochondrial markers (Figure 2) , probably indicative of incomplete cellular disruption (at least 25% nonlysed cells as measured by microscopic analysis, data not shown), and was 435 therefore not used for further analysis. The relative distribution 436 of a particular marker was not affected by MPTP treatment (refer 437 to Supplementary Data 4). 438
Effects of Subcytotoxic MPTP Treatments on the Mitochondrial Proteome
Mitochondrial fractions from cells treated with 1 mM MPTP for 24 h were analyzed using 2DE. Figure 3 shows 2DE profiles for treated and control samples using either broad (pH 3~ 10 linear) or narrower (pH 5~8) pH gradient strips. Using the broad range strips, approximately 350 spots were detected. Up to 6 proteins showed changes in levels following MPTP treatment with p < 0.05 using the software's in-built paired t test. To ensure detection of as many differentially expressed proteins as possible, spots showing a change with a probability p < 0.1 (n -3), discriminated from spots with p < 0.05, were also selected for identification and for validation analysis, leading to the identification of at least 14 differentially expressed proteins following treatment. Most of these changes were in the basic area of the gel. Enriching the neutral pH area (pH 5 -8) showed that more proteins were affected (13 spots) by the toxin treatment than observed using the broad pH gradient strips in the same area. Combining both analyses, 27 spots were either up-or downregulated following exposure to MPTP of which 16 were identified. Table 1 shows the list of identified proteins affected by subcytotoxic concentrations of MPTP, including proteins from the chaperone family, metabolic enzymes, subunits of oxidative phosphorylation and membrane proteins. Most of these proteins are either known to have distinct localizations in mitochondria, or to be ubiquitously distributed within a cell.
Validation of Potential Markers of MPTP Subcytotoxicity
To confirm the changes observed, some of these proteins were further analyzed by probing Western blots with specific antibodies. In addition to mitochondria-enriched fractions, the levels of these proteins were measured in unfractionated ('total') extracts and cytoplasmic fractions. The Western blotting data (top of each panel, Figure 4) shows that, except for Hsc70 (localized ubiquitously in the cell), proteins were found in lower levels in the cytoplasmic fraction, in line with specific localization to mitochondria. More particularly, VDAC1 and ATP synthase-d were not detected in the cytoplasmic fraction (Western blot images shown in Figure 4B ,C). Western blot analysis indicated that all proteins whose levels in the mitochondrial proteome changed following MPTP treatment showed the same trend using Western blot analysis. Specifically, FMH, VDAC1, ATP synthase-d, GOT2, Hsp60 and Hsc70 were all significantly upregulated in mitochondria following treatment, validating the results from the 2DE analysis ( Figure 4 and Table 2 ).
In general, the percentage changes were higher using the Western blot analysis than the 2DE approach. Western blot analysis of the mitochondrial protein ATP synthase a-subunit, chosen as a control since 2DE indicated that its level did not significantly change following MPTP treatment, also revealed no change in its level (Table 2) .
Hsc70 levels increased in the mitochondria-enriched fraction but this increase was not detectable in total extracts due to the fact that there was no increase in the cytoplasmic fraction, where it was most prevalent ( Figure 4D) . Two-dimensional gel electrophoresis technology can separate isoforms of the same protein, whereas ID-Western blot analysis provides a measure of total protein levels within a single band. Therefore, further analysis focusing on isoforms of the same protein was carried out for the heat shock proteins and VDAC1 using 2D-Western blot analysis. Figure 5A (left panel) shows that two Hsc70 isoforms were detected using Western blotting. The main spot (spot 15') was identified as Hsc70 (refer to Supplementary Data 1 and Figure 5A right found to be affected by MPTP treatment (Figure 3 ). In contrast, the smaller acidic spot (spot 15, Figure 5A ) became more prominent following treatment with MPTP ( Figure 3 ). Up to three Hsp60 isoforms were detected by Western blotting: the predominant spot, colocalizing with spot 19 from Figure 3 (also right panel Figure 5B ), plus two smaller spots of same molecular weight ( Figure 5B, left panel) . Only the main central spot increased in levels following MPTP treatment.
2D-blot analysis revealed a number of VDAC1 spots; the main spot (spot ll) was associated with three small relatively acidic spots and a number of isoforms (represented as a smear) with a more alkaline isoelectric point ( Figure 5C, left panel) . The main spot stained more intensely on 2D-blots of MPTP-treated cell extracts.
• DISCUSSION si6
Effects of Subcytotoxic Concentrations of MPTP on the 517 Mitochondrial Proteome from Mouse N2a Neuroblastoma sis In the present study, treatment with up to 1 mM MPTP for 24 519 h was considered subcytotoxic in differentiated mouse N2a cells; 520 cell viability assessed using trypan blue exclusion and MTT 521 reduction was not affected but morphological changes and 522 reduced ATP levels were observed. Interestingly, even though 523 ATP levels were reduced following treatment with low MPTP 524 concentrations (as low as 10 fiM), cell death only significantly 525 occurred when more than 50% ATP was depleted suggesting that 526 a threshold ATP level (20-50% of controls in the present model, 527 Figure 1A ) might be required for maintaining the survival of the 528 Figure 4 was compared to 2DE analysis (data presented in Figure 3) . ATP synthase-a was used as a control protein, exhibiting no changes in levels. *Statistically significant changes p < 0.05 using a paired t test. Statistically significant changesp < 0.1 using a paired r test. ATP synthase-a, ATP synthase a-subunit isoform 1; ATPsynthase-d, ATP synthase subunit d; FMH, fumarase; GOT2, glutamate oxaloacetate transaminase 2; HSP60, 60 kDa heat shock protein; HSPA8, heat shock cognate 71 kDa; VDAC1, voltagedependent-anion channel 1.
A. Girolamo and colleagues showed that a reduction in axonal outgrowth was linked to hyperphosphorylation of neurofila-534 ments NF-H, leading to a change in the stability of the cytoske-535 leton. Similarly to the present study, this phenomenon occurred 536 prior to cell death. 537 To focus on mitochondrial dysfunction, mitochondria were 538 enriched from differentiated mouse N2a cells. The use of markers 539 for each subcellular fraction showed that the resulting mitochon-540 drial preparation was highly enriched in mitochondrial proteins, 541 contained low levels of lysosomal proteins and traces of cyto-542 plasmic and endoplasmic reticulum proteins (Figure 2) . Only 543 10% of the identified proteins from the mitochondrial proteome 544 2DE profile were not specific to mitochondria (refer to Supple-545 mentary Data 2 for localization of each identified protein), 546 including proteins normally found in the cytosol and endoplas-547 mic reticulum, confirming the subcellular marker data. The 548 purity of the mitochondria-enriched fraction and 2DE profile 549 was comparable with the study of Scheffler and colleagues (3.7-550 fold mitochondrial enrichment, low contamination levels) and 551 better than that observed in the study of Pennington and collea-552 gues.
553 Proteomic analysis using the 2DE approach showed that the 554 levels of 27 proteins changed following MPTP treatment and 16 555 of these proteins were identified. Because of a relatively low 556 statistical power (p < 0.1 using paired t test; n -3), validation of 557 the approach was essential. The availability of well characterized 558 commercial antibodies allowed further analysis of expression 559 levels of six proteins using Western blot analysis; changes in 560 expression of these proteins were confirmed, validating the 2DE data. S6i The differentially expressed proteins were from different 562 cellular pathways. Dysregulation in protein folding was indicated 563 by increased levels of some chaperone family proteins, such as the 564 ubiquitous heat shock cognate 71 kDa (Hsc70) and stress-565 induced protein 1 (STIPl), the cytoplasmic T-complex pro-566 tein-1 £-subunit (TCPE) and the mitochondrial 60 kDa heat 567 shock protein (Hsp60), and with decreased levels of endoplasmic 568 reticulum resident protein 29 (ERP29) in the mitochondrial 569 fraction. The levels of proteins involved in several metabolic 570 pathways were increased following MPTP-treatment, including: 571 MDH and FMH (Krebs cycle), GOT2 (amino acid metabolism), 572 ECHM and ETFa (fatty acid /5-oxidation), SCOT1 (ketone 573 body metabolism), enolase (glycolysis) and ATP synthase-d 574 (oxidative phosphorylation). Two membrane proteins were also 575 affected with increased levels of VDAC1 and decreased levels of 576 mitofilin. The present study showed that many mitochondrial 577 pathways could be affected by MPTP treatment prior to cell death. 578
Changes in Metabolic Pathways 579 While ATP levels were reduced by 50% following MPTP 580 treatment, ATP synthase subunit d levels (ATP synthase-d) ssi increased, whereas ATP synthase Fl complex a-subunit (ATP 582 synthase-a) levels were unaffected. These different effects on the 583 two subunits within complex V were not unexpected given that 584 the subunits have different functions, with the a-subunit binding 585 nucleotides and subunit-d participating in stabilizing the F1/F0 586 complex. Increased subunit-d could be a compensatory me-587 chanism in response to declining ATP levels. Indeed, these 588 results agree with the observations of Basso and colleagues in 589 human post-mortem samples of the substantia nigra, and thereby 590 support the use of the N2a model for this type of analysis. Figure 6 . An increase in enolase suggests an activation of 597 the glycolytic pathway, thought to be protective in MPTP-induced 598 toxicity models via the production of more ATP. 6 "' 61 Fatty acid 599 oxidation may also be increased in our model, suggested by increased 600 levels of ETFa and ECHM, again leading to more ATP production. 601
One consequence of complex I inhibition is the inability to 602 reoxidize NADH via the electron transfer chain. It has been 603
proposed that the reversal of the MDH step to produce malate 604 may protect mouse N2a cells against MPTP toxicity, also allowing 605 NADH reoxidation. Therefore, it is possible that the increased 606 levels of MDH reported in the present study reflect an attempt to 607 reoxidize NADH. Evidence of FMH involvement has not been 608 observed in other PD studies but one can speculate that increased 609 FMH levels may similarly serve the purpose of increasing the 6io production of malate as a substrate for cytosolic energy production 611 ( Figure 6 ). The consequence of increased levels of GOT2 is not 612 known in the present model but it should be noted that a previous 613 study of the effects of MPTP on monkeys showed that MDH and 614 GOT2 activities were increased. Glutamate oxaloacetate transami-615 nase 2 (GOT2), also called mitochondrial aspartate aminotransfer-616 ase, is linked to the Krebs cycle ( Figure 6 ) in the mitochondrial 617 matrix. Increased extracellular glutamate levels have previously 618 been described in PD and following MPTP-induced toxicity. A 619 role for glutamate excitotoxicity in cell death following MPTP-620 induced toxicity has been observed in a mouse model and 621 GOT2 increased levels might be involved in the process linking 622 metabolic dysregulation and glutamate excitotoxicity.
A consequence of an inability to oxidize acetylCoA may also be evident since the levels of SCOTl, involved in ketone body formation, are increased. Ketone body formation has previously been described as a protective mechanism of cells in PD models. ' However, changes in levels of SCOTl have not previously been reported in relation to complex I inhibition.
Chaperone Family Proteins
The levels of four chaperones within the mitochondria were increased in response to MPTP treatment. This type of response has commonly been reported under oxidative stress, often linked to protein aggregation and degradation impairment, as observed in PD models and MPTP-induced models. 8, 11, 70 Increased levels of Hsc70, an ubiquitous protein, were only evident in the mitochondria-enriched fraction where an acidic isoform of the protein was specifically affected. Changes in posttranslational modifications to Hsc70 have been previously observed in a number of models including nitration, oxidation and phosphorylation. The exact cause of the shift in pi in the present study and the consequence on mitochondrial location and chaperone function require further study. Hsc70 is involved in folding proteins as they exit ribosomes and in delivering proteins for degradation by both the ubiquitin-proteasome system and the lysosomes. It was also observed to play a protective role in MPTP toxicity in a variety of models and is found in Lewy bodies. ' Of particular significance for the present study is the fact that Hsc70 also has a key role in the transport of specific proteins into mitochondria. As for most VDAC protein and mRNA levels were observed to be elevated following rotenone-induced toxicity in Human SH-SY5Y neuro-711 nal cells. The present study showed that another complex I 712 inhibitor, MPTP, also modulated VDAC 1 protein levels, and that 713 this occurred prior to neuronal death. It would therefore appear 714 that VDACl up-regulation is a potential early marker of MPTP-715 induced cell death. Moreover, Lessner and colleagues found 716 that VDACl levels were increased in striatal extracts in a 717 6-OHDA-hemiparkinsonian rat model of PD while Perriquet 718 and colleagues reported that VDACl levels increased in the 719 striatum and cortex of Parkin knockdown mice (used as a genetic 720 model of PD). Finally, VDACl has recently been reported to be 721 necessary for PINKl/Parkin-directed autophagy of damaged 722 mitochondria.
Thus, changes in VDAC may have a wider 723 significance than previously thought in PD. In the present study, 724 up to four different spots with different isoelectric points were 725 detected using 2D-blot analysis, showing that the protein can 726 exhibit multiple post-translational modifications, which could 727 influence VDACl function following MPTP treatment. 728
• CONCLUSIONS 729
The present study showed that several cellular pathways were 730
affected by MPTP-induced toxicity prior to cell death. This has 731 provided a more specific molecular insight into the pathways that are 732 initially affected following complex I impairment. Up-regulation of 733 several chaperone proteins in MPTP treated cells was observed, 734 suggesting a link between metabolic changes due to complex 1 735 inhibition and protein folding. Similarly, extra-mitochondrial pro-736 teins, most of them known to be able to associate with mitochondria, 737 were also affected following mitochondrial impairment showing that 738 the insult was spreading to the rest of the cell. It is suggested here that 739 VDAC 1, a multifunction outer mitochondrial membrane, could have 740 a key role in signaling between mitochondria and the rest of the cell. 741 It could also be considered as a subcytotoxic biomarker of imminent 742 cell death and we propose that further study should be undertaken to 743 establish the precise role of VDAC in PD-linked cell death. Since 744 complex 1 dysfunction is a biochemical characteristic described in 745 Parkinson's disease, we believe that our work provides newimportant 746 information of relevance to this condition. 747
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